Ask AI
Bill106th CongressFiled Sep 23, 1999Commerce
H.R. 2927

Affordable Prescription Drugs Act

Bill journey · stage 1 of 5

Just introduced

Filed
Comm.
Floor
Both
Law

What it doesSummary introduced in house (Sep 23, 1999)

Affordable Prescription Drugs Act - Amends Federal patent law to grant the Secretary of Health and Human Services the right to establish compulsory licensing (without authorization of the right holder) for nonexclusive, nonassignable use of certain patented medical inventions upon a determination that: (1) the patent holder, contractor, exclusive licensee, or assignee has not taken, or is not expected to take within a reasonable time, effective steps to achieve practical application of the subject invention in a field of use; (2) such compulsory license is necessary to alleviate health or safety needs which are not adequately satisfied by the patent holder, contractor, licensee, or assignee; or (3) the patented material is priced higher than may be reasonably expected based on criteria developed by the Secretary of Commerce.

Requires any person engaged in the manufacture and sale of any new drug or new animal drug approved under the Federal Food, Drug, and Cosmetic Act, for which a patent is still in effect, to report annually to Congress an audit of all financial information relevant to that drug's pricing nationally and internationally, including research and development costs, sufficient to assess the reasonableness of that pricing. Requires disqualification from participation in Federal programs as a penalty for noncompliance with this reporting requirement.

What just happenedMar 21, 2000

Sponsor introductory remarks on measure. (CR H1127)

Who’s behind it

Rep. Brown, Sherrod [D-OH-13](D-OH)Sponsor
11 cosponsors10 D1 I
Read on Congress.gov
11cosponsors2committees12actions23subjects
  1. Mar 21, 2000IntroReferralB00100

    Sponsor introductory remarks on measure. (CR H1127)

  2. Nov 1, 1999IntroReferralB00100

    Sponsor introductory remarks on measure. (CR H11148)

  3. Oct 18, 1999IntroReferralB00100

    Sponsor introductory remarks on measure. (CR H10154)

  4. Oct 8, 1999CommitteeH11000

    Referred to the Subcommittee on Health and Environment.

    Health and Environment Subcommittee
  5. Oct 4, 1999CommitteeH11000

    Referred to the Subcommittee on Courts and Intellectual Property.

    Courts, Intellectual Property, Artificial Intelligence, and the Internet Subcommittee
  6. Sep 30, 1999IntroReferralB00100

    Sponsor introductory remarks on measure. (CR H9176-9177)

  7. Sep 23, 1999IntroReferralH11100

    Referred to the Committee on the Judiciary, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Energy and Commerce Committee
  8. Sep 23, 1999IntroReferralH11100-A

    Referred to the Committee on the Judiciary, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  9. Sep 23, 1999IntroReferralH11100

    Referred to the Committee on the Judiciary, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Judiciary Committee
  10. Sep 23, 1999IntroReferralB00100

    Sponsor introductory remarks on measure. (CR H8622)

  11. Sep 23, 1999IntroReferralIntro-H

    Introduced in House

  12. Sep 23, 1999IntroReferral1000

    Introduced in House